Filters
Venetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimen
Venetoclax is an effective therapy for chronic lymphocytic leukemia (CLL) with the potential to induce deep remissions.1-5 Furthermore, venetoclax in combination).2 As fixed-duration venetoclax-based therapies are increas...
Hematology
- 2022 •
- Jimp •
- Link
Rok uplatnění
Jimp - Článek v periodiku v databázi Web of Science
Výsledek na webu
VENETOCLAX WITH AZACYTIDINE IN THE TREATMENT OF MOLECULAR RELAPSE OF ACUTE MYELOID LEUKEMIA
VENETOCLAX WITH AZACYTIDINE IN THE TREATMENT OF MOLECULAR RELAPSE OF ACUTE MYELOID LEUKEMIA - conference abstract.
Hematology
- 2024 •
- O
Rok uplatnění
O - Ostatní výsledky
WHAT IS THE REAL FATE OF “UNFIT” ACUTE MYELOID LEUKEMIA (AML) PATIENTS IN THE VENETOCLAX ERA?
WHAT IS THE REAL FATE OF “UNFIT” ACUTE MYELOID LEUKEMIA (AML) PATIENTS IN THE VENETOCLAX ERA? - conference abstract.
Hematology
- 2024 •
- O
Rok uplatnění
O - Ostatní výsledky
Evaluation of minimal residual disease in patients with De Novo acute myeloid leukemia treated with Azacitidine and Venetoclax combination therapy.
Evaluation of minimal residual disease in patients with De Novo acute myeloid leukemia treated with Azacitidine and Venetoclax combination therapy - conference abstract....
Hematology
- 2023 •
- O
Rok uplatnění
O - Ostatní výsledky
Blockage of BCL-XL overcomes venetoclax resistance across BCL2-positive lymphoid malignancies irrespective of BIM status
Venetoclax, a BCL2 inhibitor, has a promising single-agent activity in mantle cell lymphoma (MCL), acute lymphoblastic leukemia (ALL), and large B-cell lymphomas we demonstrated strong synergy between venetoclax and A1155463, a BCL-...
Hematology
- 2024 •
- Jimp •
- Link
Rok uplatnění
Jimp - Článek v periodiku v databázi Web of Science
Výsledek na webu
VENETOCLAX + AZACYTIDINE THERAPY IN PATIENTS WITH ACUTE MYELOID LEUKAEMIA (AML) RARELY RESULTS IN THE ELIMINATION OF THE LEUKAEMIC CLONE, EVEN WHEN MORPHOLOGICAL REMISSION IS PRESENT
VENETOCLAX + AZACYTIDINE THERAPY IN PATIENTS WITH ACUTE MYELOID LEUKAEMIA (AML) RARELY RESULTS IN THE ELIMINATION OF THE LEUKAEMIC CLONE, EVEN WHEN MORPHOLOGICAL REMISSION IS PRESENT - conference abstract....
Hematology
- 2024 •
- O
Rok uplatnění
O - Ostatní výsledky
Azacitidine and venetoclax in previously untreated acute myeloid leukemia
to venetoclax had promising efficacy in a previous phase 1b study. Methods: We randomly of age or older, or both to azacitidine plus either venetoclax or placebo. All); venetoclax (target dose, 400 mg) or matching placebo ...
Hematology
- 2020 •
- Jimp •
- Link
Rok uplatnění
Jimp - Článek v periodiku v databázi Web of Science
Výsledek na webu
Cotargeting of BCL2 with Venetoclax and MCL1 with S63845 Is Synthetically Lethal In Vivo in Relapsed Mantle Cell Lymphoma
Purpose: Mantle cell lymphoma (MCL) is an aggressive subtype of B-cell non-Hodgkin lymphomas characterized by (over) expression of BCL2. A BCL2-targeting drug, venetoclax, has promising anticancer activity in MCL. We analyzed molecular mecha...
Oncology
- 2019 •
- Jimp •
- Link
Rok uplatnění
Jimp - Článek v periodiku v databázi Web of Science
Výsledek na webu
Long-term follow-up of VIALE-A: Venetoclax and azacitidine in chemotherapy-ineligible untreated acute myeloid leukemia
Venetoclax-azacitidine is approved for treatment of patients with newly with venetoclax-azacitidine. Patients with newly diagnosed AML who were ineligible for intensive chemotherapy were randomized 2:1 to receive venetoclax...
Hematology
- 2024 •
- Jimp •
- Link
Rok uplatnění
Jimp - Článek v periodiku v databázi Web of Science
Výsledek na webu
Cotargeting of BCL2 with Venetoclax and MCL1 with S63845 Is Synthetically Lethal In Vivo in Relapsed Mantle Cell Lymphoma
Purpose: Mantle cell lymphoma (MCL) is an aggressive subtype of B-cell non-Hodgkin lymphomas characterized by (over) expression of BCL2. A BCL2-targeting drug, venetoclax, has promising anticancer activity in MCL. We analyzed molecular mecha...
Biochemistry and molecular biology
- 2019 •
- Jimp •
- Link
Rok uplatnění
Jimp - Článek v periodiku v databázi Web of Science
Výsledek na webu
- 1 - 10 out of 94